A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal CancerJ. Randolph Hecht, Rafael G. Amado|Journal of Clinical Oncology|2008Cited by 852
A randomized, double-blind, placebo-controlled, phase III study in patients (Pts) with metastatic adenocarcinoma of the colon or rectum receiving first-line chemotherapy with oxaliplatin/5-fluorouracil/leucovorin and PTK787/ZK 222584 or placebo (CONFIRM-1)J. Randolph Hecht, Christian Jacques, E. Jaeger et al.|Journal of Clinical Oncology|2005Cited by 201
Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junctionZ.A. Wainberg, J. Randolph Hecht|British Journal of Cancer|2011Cited by 85